Arrhythmia Research Technology appoints independent director
Courtesy Photo
Fitchburg’s Arrhythmia Research Technology has appointed an independent director at the urging of an activist investor who holds 11 percent of the company’s stock.
The contract engineering company appointed Bryan S. Ganz to its Board of Directors, effective Feb. 1. He will serve on the board through the company’s annual meeting later in the year. Ganz is currently the CEO of Northeast Remediation LLC of Wakefield, a firm he founded in 2013 that is engaged in the removal of lead paint, asbestos and mold. He is also the CEO of Scudder Bay Capital, LLC, a real estate investment company focused on creating affordable rental housing options through the purchase, rehabilitation and ownership of distressed properties in Massachusetts, Rhode Island and Connecticut.
Ganz’s appointment was recommended to the board by the holder of approximately 11 percent of the company’s outstanding stock. However, Paul Walter, chairman of the board, said that Ganz has seen a great deal of success and the board looks forward to benefiting from his input as the company’s growth strategy is crafted.
WBJ Web Partners
Most Recent
Most Recent
0 Comments